viewOptiBiotix Health PLC

OptiBiotix Health extends German deal to add gut health product to roster

The company is a specialist in the human microbiome, the ecosystem of bacteria that resides in the gut and on the skin

OptiBiotix Health PLC -
Pictured is the gut microbiome in action

OptiBiotix Health PLC (LON:OPTI) said its agreement with Draco Ingredients has been extended to include a second product.

As well as distributing weight management line SlimBiome in Germany, it is adding to the roster WellBiome, developed to promote gut health.

“The introduction of WellBiome gives us the opportunity to extend our product portfolio of functional ingredients with scientifically proven benefits and increase the commercial opportunity,” Andre Wittke, Draco’s general manager said in a statement.

“There is growing awareness of the link between gut health and general wellbeing in Germany and WellBiome creates  a ‘ready for market’ opportunity to access this growing health and wellbeing trend,” he added.

OptiBiotix is a specialist in the human microbiome, the ecosystem of bacteria that resides in the gut and on the skin.

Its new approach to wellbeing has seen it develop compounds to tackle obesity, high cholesterol and diabetes.

The Draco deal is one in a growing line of commercial tie-ups that has seen the international roll-out of products.

Quick facts: OptiBiotix Health PLC

Price: 53.75001 GBX

Market: AIM
Market Cap: £47.27 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of OptiBiotix Health PLC named herein, including the promotion by the Company of OptiBiotix Health PLC in any Content on the Site, the Company...



OptiBiotix Health expands key deals for its WellBiome and CholBiome

OptiBiotix Health PLC's (LON:OPTI) Stephen O'Hara speaks to Proactive's Andrew Scott after announcing thy've amended its relationship with CTC Group, the company that is distributing and selling its CholBiomex3 product in the Philippines. The new agreement extends the product range from the...

2 weeks, 4 days ago

2 min read